| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/05/1999 | WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness |
| 08/05/1999 | WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51 |
| 08/05/1999 | WO1999025843A3 Human checkpoint kinase, hcds1, compositions and methods |
| 08/05/1999 | WO1999022763A3 Encapsulated immunomodulators useful as vaccine adjuvants |
| 08/05/1999 | WO1997010824A8 Use of 5ht1b receptor antagonist for the treatment of vascular disease |
| 08/05/1999 | CA2819705A1 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | CA2755452A1 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | CA2319698A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
| 08/05/1999 | CA2319195A1 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | CA2319143A1 Modulation of sodium channels in dorsal root ganglia |
| 08/05/1999 | CA2319129A1 67 human secreted proteins |
| 08/05/1999 | CA2319087A1 Methods and apparatus for accelerated orthokeratology |
| 08/05/1999 | CA2318833A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine |
| 08/05/1999 | CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis |
| 08/05/1999 | CA2318215A1 Platelet aggregation inhibition using low molecular weight heparin in combination with a gp iib/iiia antagonist |
| 08/05/1999 | CA2317814A1 Human protein kinase molecules |
| 08/05/1999 | CA2317459A1 Methods of identifying modulators of kinases responsive to stress |
| 08/04/1999 | EP0933372A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 08/04/1999 | EP0932675A2 Epidermal differentiation factor |
| 08/04/1999 | EP0932665A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 08/04/1999 | EP0932420A1 Drug delivery using terminal complement components |
| 08/04/1999 | EP0932416A2 Method and potentiated composition for treating migraine |
| 08/04/1999 | EP0932402A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 08/04/1999 | EP0854720B1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 08/04/1999 | EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a |
| 08/04/1999 | EP0665739B1 Morphogen-induced periodontal tissue regeneration |
| 08/04/1999 | EP0585242B1 Wound healing |
| 08/03/1999 | US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs. |
| 08/03/1999 | US5932701 ribA |
| 08/03/1999 | US5932609 Pharmaceutical composition for inhibiting the growth of cancers |
| 08/03/1999 | US5932604 Pharmaceutical compositions for the treatment of viral infections |
| 08/03/1999 | US5932602 Treatment of platelet derived growth factor related disorders such as cancers |
| 08/03/1999 | US5932589 Oral drug |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |
| 08/03/1999 | US5932562 Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same |
| 08/03/1999 | US5932560 Treatment of conditions and disease |
| 08/03/1999 | US5932558 Adenosine receptor agonists for the promotion of wound healing |
| 08/03/1999 | US5932542 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
| 08/03/1999 | US5932425 Compositions and methods for modulating cellular NF-κB activation |
| 08/03/1999 | US5932423 Cyclic nucleotide phosphodiesterases |
| 08/03/1999 | US5932236 Pharmaceutical composition and methods for using it |
| 08/03/1999 | US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema |
| 08/03/1999 | CA1340692C Method of potentiating an immune response and compositions therefor |
| 07/30/1999 | CA2246001A1 Novel compounds |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037790A1 Human calcineurin b-like protein |
| 07/29/1999 | WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | WO1999037753A1 Enzyme catalyzed therapeutic agents |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999037303A1 Combination of a gaba-a alpha 2/3 agonist and a selective serotonin reuptake inhibitor |
| 07/29/1999 | WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
| 07/29/1999 | WO1999037155A1 Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances |
| 07/29/1999 | WO1999037150A1 Transcription therapy for cancers |
| 07/29/1999 | WO1999025360A3 Progestogen-antiprogestogen regimens |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999015183A9 PROTEASOME INHIBITORS, UBIQUITIN PATHWAY INHIBITORS OR AGENTS THAT INTERFERE WITH THE ACTIVATION OF NF-λB VIA THE UBIQUITIN PROTEASOME PATHWAY TO TREAT INFLAMMATORY AND AUTOIMMUNE DISEASES |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | CA2319121A1 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
| 07/29/1999 | CA2317424A1 Combination of a gaba-a alpha 2/3 agonist and a selective serotonin reuptake inhibitor |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 07/28/1999 | EP0931147A1 ANTI-ErbB2 ANTIBODIES |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 07/28/1999 | EP0930885A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 07/28/1999 | EP0930876A2 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 07/28/1999 | EP0930831A1 Flavonol containing food supplements |
| 07/27/1999 | US5929122 Combination preparation containing tramadol and a calcium channel antagonist |
| 07/27/1999 | US5929104 Method for inducing apoptosis of cancer cell |
| 07/27/1999 | US5929065 Adminsitering a patient suffering from sleep disorder a hypnotically effective amount of 4,5,6,7-tetrahydroisoxaxole(5,4-c)pyridine-3-ol(thip) |
| 07/27/1999 | US5929061 Method for treating vascular headaches |
| 07/27/1999 | US5929055 Tetracycline |
| 07/27/1999 | US5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5929039 Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | US5928895 IgA Fc binding protein |
| 07/27/1999 | US5928874 Nek1-related protein kinase |
| 07/27/1999 | US5928654 Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors |
| 07/27/1999 | US5928639 Immunotherapy of cancer with allogeneic lymphocytes |
| 07/27/1999 | US5927283 Treating diseases involving oxygen deficiency, in wound healing, and in restoring oxygen affinity of stored blood. |
| 07/27/1999 | CA2215327C Formulations for lipophilic compounds |
| 07/27/1999 | CA2170622C Oral formulations of an antifungal |
| 07/22/1999 | WO1999036570A2 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036531A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN |
| 07/22/1999 | WO1999036100A2 Polymeric carrier |
| 07/22/1999 | WO1999036095A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036083A1 Methods of neuroendocrine regulation of affective disorders |